New celiac drug trial aims to protect against gluten reactions
Symptom relief
Recruiting now
This early-stage trial tests a new medicine called VTP-1000 in 45 adults with celiac disease. The main goal is to see if it is safe and how the body handles it. Some participants will also eat gluten in a controlled way to see if the drug helps reduce reactions. This study is a f…
Phase: EARLY_PHASE1 • Sponsor: Barinthus Biotherapeutics • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC